-
1
-
-
79952201221
-
Chapter 2: preclinical evaluation of juvenile toxicity
-
Barrow P., Barbellion S., Stadler J. Chapter 2: preclinical evaluation of juvenile toxicity. Methods Mol. Biol. 2011, 691:17-35.
-
(2011)
Methods Mol. Biol.
, vol.691
, pp. 17-35
-
-
Barrow, P.1
Barbellion, S.2
Stadler, J.3
-
2
-
-
84864465909
-
Human milk oligosaccharides: every baby needs a sugar mama
-
Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012, 22(9):1147-1162.
-
(2012)
Glycobiology
, vol.22
, Issue.9
, pp. 1147-1162
-
-
Bode, L.1
-
3
-
-
0343484259
-
Evaluation of safety of inulin and oligofructose as dietary fiber
-
Carrabin I.G., Flamm G. Evaluation of safety of inulin and oligofructose as dietary fiber. Regul. Toxicol. Pharmacol. 1999, 30:268-282.
-
(1999)
Regul. Toxicol. Pharmacol.
, vol.30
, pp. 268-282
-
-
Carrabin, I.G.1
Flamm, G.2
-
4
-
-
0031571579
-
Milk oligosaccharide profiles by reversed-phase HPLC of their perbenzoylated derivatives
-
Chaturvedi P., Warren C.D., Ruiz-Palacios G.M., et al. Milk oligosaccharide profiles by reversed-phase HPLC of their perbenzoylated derivatives. Anal. Biochem. 1997, 251:89-97.
-
(1997)
Anal. Biochem.
, vol.251
, pp. 89-97
-
-
Chaturvedi, P.1
Warren, C.D.2
Ruiz-Palacios, G.M.3
-
5
-
-
0034917101
-
Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation
-
Chaturvedi P., Warren C.D., Altaye M., et al. Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 2001, 11(5):365-372.
-
(2001)
Glycobiology
, vol.11
, Issue.5
, pp. 365-372
-
-
Chaturvedi, P.1
Warren, C.D.2
Altaye, M.3
-
6
-
-
0027518583
-
Changes in carbohydrate composition in human milk over 4months of lactation
-
Coppa G.V., Gabrielli O., Pierani P., et al. Changes in carbohydrate composition in human milk over 4months of lactation. Pediatrics 1993, 91:637-641.
-
(1993)
Pediatrics
, vol.91
, pp. 637-641
-
-
Coppa, G.V.1
Gabrielli, O.2
Pierani, P.3
-
7
-
-
0032831862
-
Oligosaccharides in human milk during different phases of lactation
-
Coppa G.V., Pierani P., Carloni I., et al. Oligosaccharides in human milk during different phases of lactation. Acta Paediatr. Suppl. 1999, 430:89-94.
-
(1999)
Acta Paediatr. Suppl.
, vol.430
, pp. 89-94
-
-
Coppa, G.V.1
Pierani, P.2
Carloni, I.3
-
8
-
-
84885217503
-
Pre-clinical safety assessment of the synthetic human milk, nature-identical, oligosaccharide Lacto-N-neotetraose (LNnT)
-
Coulet M., Phothirath P., Constable A., et al. Pre-clinical safety assessment of the synthetic human milk, nature-identical, oligosaccharide Lacto-N-neotetraose (LNnT). Food Chem. Toxicol. 2013, 62:528-537.
-
(2013)
Food Chem. Toxicol.
, vol.62
, pp. 528-537
-
-
Coulet, M.1
Phothirath, P.2
Constable, A.3
-
9
-
-
84889683064
-
-
EMEA, Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications. Ref. EMEA/CHMP/SWP/169215/2005.
-
EMEA, 2008. Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications. Ref. EMEA/CHMP/SWP/169215/2005.
-
(2008)
-
-
-
10
-
-
0034091407
-
Variability of human milk neutral oligosaccharides in a diverse population
-
Erney R.M., Malone W.T., Skelding M.B., et al. Variability of human milk neutral oligosaccharides in a diverse population. J. Pediatr. Gastroenterol. Nutr. 2000, 30(2):181-192.
-
(2000)
J. Pediatr. Gastroenterol. Nutr.
, vol.30
, Issue.2
, pp. 181-192
-
-
Erney, R.M.1
Malone, W.T.2
Skelding, M.B.3
-
11
-
-
35148891167
-
Efforts to emulate human milk oligo-saccharides
-
Espinosa R.M., Tamez M., Prieto P. Efforts to emulate human milk oligo-saccharides. Br. J. Nutr. 2007, 8(Suppl. 1):S74-S79.
-
(2007)
Br. J. Nutr.
, vol.8
, Issue.SUPPL. 1
-
-
Espinosa, R.M.1
Tamez, M.2
Prieto, P.3
-
12
-
-
84878216058
-
Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment
-
Everds N.E., Snyder P.W., Bailey K.L., et al. Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol. Pathol. 2013, 41(4):560-614.
-
(2013)
Toxicol. Pathol.
, vol.41
, Issue.4
, pp. 560-614
-
-
Everds, N.E.1
Snyder, P.W.2
Bailey, K.L.3
-
13
-
-
84867731329
-
Biotechnological production of human milk oligosaccharides
-
Han N.S., Kim T.J., Park Y.C., et al. Biotechnological production of human milk oligosaccharides. Biotechnol. Adv. 2012, 30(6):1268-1278.
-
(2012)
Biotechnol. Adv.
, vol.30
, Issue.6
, pp. 1268-1278
-
-
Han, N.S.1
Kim, T.J.2
Park, Y.C.3
-
14
-
-
83055184171
-
The role of oligosaccharides from human milk and other sources in prevention of pathogen adhesion
-
Hickey R.M. The role of oligosaccharides from human milk and other sources in prevention of pathogen adhesion. Int. Dairy J. 2012, 22:141-146.
-
(2012)
Int. Dairy J.
, vol.22
, pp. 141-146
-
-
Hickey, R.M.1
-
15
-
-
70449378043
-
Safety of a novel galacto-oligosaccharide: genotoxicity and repeated oral dose studies
-
Kobayashi T., Yasutake N., Uchida K., et al. Safety of a novel galacto-oligosaccharide: genotoxicity and repeated oral dose studies. Hum. Exp. Toxicol. 2009, 28(10):619-630.
-
(2009)
Hum. Exp. Toxicol.
, vol.28
, Issue.10
, pp. 619-630
-
-
Kobayashi, T.1
Yasutake, N.2
Uchida, K.3
-
16
-
-
0033826695
-
Oligosaccharides in human milk: structural, functional, and metabolic aspects
-
Kunz C., Rudloff S., Baier W., et al. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu. Rev. Nutr. 2000, 20:699-722.
-
(2000)
Annu. Rev. Nutr.
, vol.20
, pp. 699-722
-
-
Kunz, C.1
Rudloff, S.2
Baier, W.3
-
17
-
-
80255135168
-
Genetic variability of human milk oligosaccharides: are there biologic consequences?
-
Williams & Wilkins, Philadelphia
-
Kunz C., Bode L., Rudloff S. Genetic variability of human milk oligosaccharides: are there biologic consequences?. Variability of Human Milk Oligosaccharides. Genetic Expression and Nutrition. Nestlé Nutrition Workshop Series, Pediatric Program 2003, vol. 50:137-152. Williams & Wilkins, Philadelphia.
-
(2003)
Variability of Human Milk Oligosaccharides. Genetic Expression and Nutrition. Nestlé Nutrition Workshop Series, Pediatric Program
, vol.50
, pp. 137-152
-
-
Kunz, C.1
Bode, L.2
Rudloff, S.3
-
18
-
-
80052661466
-
Method for milk oligosaccharide profiling by 2-aminobenzamide labeling and hydrophobic interaction chromatography
-
Marino K., Lane J.A., Abrahams J.L., et al. Method for milk oligosaccharide profiling by 2-aminobenzamide labeling and hydrophobic interaction chromatography. Glycobiology 2011, 21(10):1317-1330.
-
(2011)
Glycobiology
, vol.21
, Issue.10
, pp. 1317-1330
-
-
Marino, K.1
Lane, J.A.2
Abrahams, J.L.3
-
19
-
-
4444241042
-
Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants
-
Morrow A.L., Ruiz-Palacios G.M., Altaye M., et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J. Pediatr. 2004, 145:297-303.
-
(2004)
J. Pediatr.
, vol.145
, pp. 297-303
-
-
Morrow, A.L.1
Ruiz-Palacios, G.M.2
Altaye, M.3
-
20
-
-
84889685074
-
-
OECD, OECD guidelines for testing of chemicals Nos. 471 and 476 Genetic Toxicology: Bacterial reverse mutation test and in vitro mammalian cell gene mutation test, respectively.
-
OECD, 1997. OECD guidelines for testing of chemicals Nos. 471 and 476 Genetic Toxicology: Bacterial reverse mutation test and in vitro mammalian cell gene mutation test, respectively.
-
(1997)
-
-
-
21
-
-
84889638555
-
-
OECD, OECD GUIDELINE for testing of chemicals No. 408. Repeated dose 90-day oral toxicity in rodents.
-
OECD, 1998. OECD GUIDELINE for testing of chemicals No. 408. Repeated dose 90-day oral toxicity in rodents.
-
(1998)
-
-
-
22
-
-
0036019911
-
A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria
-
Priem B., Gilbert M., Wakarchuk W.W., et al. A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria. Glycobiology 2002, 12(4):235-240.
-
(2002)
Glycobiology
, vol.12
, Issue.4
, pp. 235-240
-
-
Priem, B.1
Gilbert, M.2
Wakarchuk, W.W.3
-
23
-
-
0013238319
-
Campylobacter jejuni binds intestinal H(O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyl oligosaccharides of human milk inhibit its binding and infection
-
Ruiz-Palacios G.M., Cervantes L.E., Ramos P., et al. Campylobacter jejuni binds intestinal H(O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyl oligosaccharides of human milk inhibit its binding and infection. J. Biol. Chem. 2003, 278:14112-14120.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 14112-14120
-
-
Ruiz-Palacios, G.M.1
Cervantes, L.E.2
Ramos, P.3
-
24
-
-
78149471642
-
Variation of human milk oligosaccharides in relation to milk groups and lactational periods
-
Thurl S., Munzert M., Henker J. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. Br. J. Nutr. 2010, 104:1261-1271.
-
(2010)
Br. J. Nutr.
, vol.104
, pp. 1261-1271
-
-
Thurl, S.1
Munzert, M.2
Henker, J.3
-
25
-
-
84866787871
-
The predominance of type I oligosaccharides is a feature specific to human breast milk
-
Urashima T., Asakuma S., Leo F., et al. The predominance of type I oligosaccharides is a feature specific to human breast milk. Adv. Nutr. 2012, 3:473S-482S.
-
(2012)
Adv. Nutr.
, vol.3
-
-
Urashima, T.1
Asakuma, S.2
Leo, F.3
-
26
-
-
84876397856
-
Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals
-
Urashima T., Taufik E., Fukuda K., et al. Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals. Biosci. Biotechnol. Biochem. 2013, 77(3):455-466.
-
(2013)
Biosci. Biotechnol. Biochem.
, vol.77
, Issue.3
, pp. 455-466
-
-
Urashima, T.1
Taufik, E.2
Fukuda, K.3
-
27
-
-
84889690594
-
-
US FDA, Guidance for industry: nonclinical safety evaluation of pediatric drug products, February 2006.
-
US FDA, 2006. Guidance for industry: nonclinical safety evaluation of pediatric drug products, February 2006.
-
(2006)
-
-
-
28
-
-
0036085947
-
Oligosaccharides in infant formula
-
Vandenplas Y. Oligosaccharides in infant formula. Br. J. Nutr. 2002, 87(Suppl. 2):S293-S296.
-
(2002)
Br. J. Nutr.
, vol.87
, Issue.SUPPL. 2
-
-
Vandenplas, Y.1
-
29
-
-
79959242589
-
Physiological and bifidogenic effects of prebiotic supplements in infant formulae
-
Veereman-Wauters G., Staelens S., Van de Broek H., et al. Physiological and bifidogenic effects of prebiotic supplements in infant formulae. J. Pediatr. Gastroenterol. Nutr. 2011, 52(6):763-771.
-
(2011)
J. Pediatr. Gastroenterol. Nutr.
, vol.52
, Issue.6
, pp. 763-771
-
-
Veereman-Wauters, G.1
Staelens, S.2
Van de Broek, H.3
-
30
-
-
0025003004
-
Variations in oligosaccharides and lactose in human milk during the first week of lactation
-
Viverge D., Grimmonprez L., Cassanas G. Variations in oligosaccharides and lactose in human milk during the first week of lactation. J. Pediatr. Gastroenterol. Nutr. 1990, 11:361-364.
-
(1990)
J. Pediatr. Gastroenterol. Nutr.
, vol.11
, pp. 361-364
-
-
Viverge, D.1
Grimmonprez, L.2
Cassanas, G.3
-
31
-
-
84884591440
-
Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines
-
Weichert, S., Jennewein, S., Hüfner, E., et al., 2013. Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines. Nutr. Res. 33, 831-838.
-
(2013)
Nutr. Res.
, vol.33
, pp. 831-838
-
-
Weichert, S.1
Jennewein, S.2
Hüfner, E.3
-
32
-
-
84889684970
-
A survey of physical growth, nutritional intake, fecal properties and morbidity of infants as related to feeding methods
-
Yamamota Y., Yonekubo A. A survey of physical growth, nutritional intake, fecal properties and morbidity of infants as related to feeding methods. Jpn. Infant 1993.
-
(1993)
Jpn. Infant
-
-
Yamamota, Y.1
Yonekubo, A.2
|